Sean M. Devlin
Impact in
- Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Oncology top 0.5%
- CAR-T cell therapy research
Papers in
- Hematology 204
- Hematopoietic Stem Cell Transplantation 105
- Acute Myeloid Leukemia Research 85
- Multiple Myeloma Research and Treatments 57
- Oncology 116
- CAR-T cell therapy research 53
- Co-authors
- Sergio Giralt (134 shared papers)Martin S. Tallman (29 shared papers)Miguel‐Angel Perales (92 shared papers)Ola Landgren (27 shared papers)Craig Steven Sauter (45 shared papers)Ross L. Levine (17 shared papers)María Juliana Arcila (12 shared papers)Molly Maloy (53 shared papers)
- Journals
- Transplantation and Cellular Therapy (95 papers)Blood (76 papers)Blood Advances (27 papers)Bone Marrow Transplantation (24 papers)Leukemia Research (7 papers)
- Partner nations
- United StatesSpainIsrael
In The Last Decade
Sean M. Devlin
326 papers receiving 15.0k citations
Sean M. Devlin's Hit Papers
Peers
Comparison fields: 5 of 136
- Hematology 5.7k
- Oncology 5.4k
- Genetics 1.9k
- Cancer Research 1.6k
- Transplantation 213
Countries citing papers authored by Sean M. Devlin
This map shows the geographic impact of Sean M. Devlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean M. Devlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean M. Devlin more than expected).
Fields of papers citing papers by Sean M. Devlin
This network shows the impact of papers produced by Sean M. Devlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean M. Devlin. The network helps show where Sean M. Devlin may publish in the future.
Co-authors
The 25 scholars most cited alongside Sean M. Devlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 348 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients Hit paper breakdown → | 2017 | 2650 |
| 2 | Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes Hit paper breakdown → | 2017 | 672 |
| 3 | Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease Hit paper breakdown → | 2015 | 607 |
| 4 | Molecular International Prognostic Scoring System for Myelodysplastic Syndromes Hit paper breakdown → | 2022 | 578 |
| 5 | Cancer therapy shapes the fitness landscape of clonal hematopoiesis Hit paper breakdown → | 2020 | 547 |
| 6 | Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation Hit paper breakdown → | 2020 | 542 |
| 7 | Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes Hit paper breakdown → | 2020 | 501 |
| 8 | Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice Hit paper breakdown → | 2016 | 471 |
| 9 | GPRC5D-Targeted CAR T Cells for Myeloma Hit paper breakdown → | 2022 | 326 |
| 10 | Lactose drives Enterococcus expansion to promote graft-versus-host disease Hit paper breakdown → | 2019 | 278 |
| 11 | 2017 | 268 | |
| 12 | 2015 | 267 | |
| 13 | Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy Hit paper breakdown → | 2022 | 258 |
| 14 | 2020 | 225 | |
| 15 | 2020 | 203 | |
| 16 | 2015 | 178 | |
| 17 | 2016 | 172 | |
| 18 | 2021 | 159 | |
| 19 | 2012 | 158 | |
| 20 | CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results Hit paper breakdown → | 2023 | 143 |
About Sean M. Devlin
Sean M. Devlin is a scholar working on Hematology, Oncology, Genetics, Transplantation and Public Health, Environmental and Occupational Health, having authored 348 papers that have together received 15.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (105 papers), Acute Myeloid Leukemia Research (85 papers), Multiple Myeloma Research and Treatments (57 papers), CAR-T cell therapy research (53 papers), Acute Lymphoblastic Leukemia research (50 papers), Lymphoma Diagnosis and Treatment (31 papers), Chronic Lymphocytic Leukemia Research (28 papers) and Protein Degradation and Inhibitors (24 papers). The work is most often cited by research in Hematology (5.7k citations), Oncology (5.4k citations), Genetics (1.9k citations), Cancer Research (1.6k citations) and Transplantation (213 citations). Sean M. Devlin has collaborated with scholars based in United States, Spain and Israel. Frequent co-authors include Sergio Giralt, Martin S. Tallman, Miguel‐Angel Perales, Ola Landgren, Craig Steven Sauter, Ross L. Levine, María Juliana Arcila, Molly Maloy, Ahmet Zehir and Parastoo Bahrami Dahi. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Advances, Bone Marrow Transplantation and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.